Pyridazine derivatives

Details Pyridazine derivatives Pyridazine derivatives

2006-10-31

2006-10-31

Habte, Kahsay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S182000, C544S215000, C544S224000, C544S238000, C514S247000, C514S248000, C514S249000, C514S252020, C514S252030, C514S252040, C514S252050, C206S570000

Reexamination Certificate

active

07129241

ABSTRACT:
Pyridazine derivatives of the formula (I) act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS

REFERENCES:
patent: 6417188 (2002-07-01), Jonas et al.
patent: 6479494 (2002-11-01), Rochus et al.
patent: WO 9806704 (1998-02-01), None
patent: WO 9965880 (1999-12-01), None
patent: WO 0157025 (2001-08-01), None

Affiliated with

Also associated with

Rating

Pyridazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridazine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3655626